Most Recent
US-based facial recognition software company Clearview AI has been ordered to cease collecting facial images from individuals in Australia and destroy all the data it has collected within the country.
Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.
Corporate advisory firm Bridge Street Capital has been hit with costs for funding the defence to a winding up application for a Sydney property developer which a judge found was “woefully” insolvent.
Three law firms and a consultancy are fighting a bid by defunct financial advisor Dover Financial to bring negligence claims against two lawyers over a so-called client protection policy found to be "an exercise in Orwellian doublespeak".
E&P Financial Group says it will defend a class action brought against it, subsidiary Dixon Advisory and director Alan Dixon, alleging they reaped millions of dollars in fees by pushing unsuitable financial products onto investors.
Epic Game's plan to lead econometric evidence in its dispute with Apple could be the first time such evidence has been led in a competition case in Australia, a judge has said, as he warned that the companies' "unlimited resources and enthusiasm for victory" should not bog the case down.
A judge has left open the possibility that aggregate damages could be awarded in a class action against US auto giant Ford on behalf of 185,000 vehicle owners over their defective cars.
Financial services company Dixon Advisory has been hit with a class action for allegedly pushing financial products onto investors that it stood to reap hundreds of millions of dollars in fees from and failing to disclose its alleged conflict of interest.
JPMorgan's general counsel for Australia and New Zealand was allowed to sit in on witness interviews during an ACCC cartel investigation into ANZ's $2.5 billion share placement despite allegedly being involved in the cartel conduct, a judge has heard.
A judge has rejected part of IVF provider Virtus Health’s bid for redactions in a recent decision from the court temporarily blocking the company from purchasing rival Adora Fertility, saying some of the confidentiality claims were “staggering” and “border on ridiculous.”